• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.27% Nasdaq Up 2.45%

    OXiGENE, Inc. (OXGN)

    -NasdaqCM
    1.16 Down 0.01(0.85%) Aug 27, 3:59PM EDT
    Add to Portfolio
    Prev Close:1.17
    Open:1.15
    Bid:0.10 x 200
    Ask:5.00 x 1200
    1y Target Est:6.25
    Beta:0.938192
    Earnings Date:Nov 10 - Nov 16 (Est.)
    Day's Range:1.14 - 1.20
    52wk Range:1.01 - 2.53
    Volume:132,347
    Avg Vol (3m):292,769
    Market Cap:30.79M
    P/E (ttm):N/A
    EPS (ttm):-0.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OXGNDown 0.85%30.79M
    AZNUp 1.54%79.91B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.55
    Quarterly EPS Est (Sep-15) :-0.14
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OXiGENE, Inc., a biopharmaceutical company, focuses on the development of vascular disrupting agents to treat cancer in the United States. Its principal clinical stage product includes fosbretabulin tromethamine, a reversible tubulin binding agent... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback